Comparison

SDZ285-428 European Partner

Item no. TMO-T4188-200mg
Manufacturer TargetMol
CASRN 174262-13-6
Amount 200mg
Category
Type Molecules
Specific against other
Citations 1.Bruno RD1,et al. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorg Med Chem. 2007 Aug 1;15(15):5047-60.
Smiles O=C(C1=CC=C(C2=CC=C(Cl)C=C2)C=C1)NCC(N3C=CN=C3)C4=CC=CC=C4
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias P450 inhibitor
Available
Bioactivity
NVP-VID-400, also known as SDZ285-428, is CYP24A1 inhibitor.
MolWt
401, 894
Pathways
Metabolism
Receptor
CYP24A1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close